Ayvakit
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72064-130 -
Package NDC
72064-130-30 -
Application number
NDA212608 -
SPL ID
6cecbec7-c35a-4993-9bb0-b16b2ad6bc21 -
SPL set ID
645c887c-8cd4-4623-8da9-ac223d71a8b9 -
UNII
513P80B4YJ -
RxCUI
2272112 -
RxCUI
2272118 -
RxCUI
2272120 -
RxCUI
2272122 -
RxCUI
2272124 -
RxCUI
2272126 -
RxCUI
2559723 -
RxCUI
2559725 -
RxCUI
2559727 -
RxCUI
2559729
What the source publishes
- Labeler
- Blueprint Medicines Corporation
- Active ingredients
- avapritinib
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ayvakit",
"splId": "6cecbec7-c35a-4993-9bb0-b16b2ad6bc21",
"labels": [
{
"setId": "645c887c-8cd4-4623-8da9-ac223d71a8b9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=645c887c-8cd4-4623-8da9-ac223d71a8b9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=645c887c-8cd4-4623-8da9-ac223d71a8b9"
}
],
"routes": [
"ORAL"
],
"labeler": "Blueprint Medicines Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-130-30)",
"package_ndc": "72064-130-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20200109"
}
],
"productId": "72064-130_6cecbec7-c35a-4993-9bb0-b16b2ad6bc21",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "72064-130",
"deaSchedule": null,
"genericName": "avapritinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AVAPRITINIB",
"strength": "300 mg/1"
}
],
"applicationNumber": "NDA212608",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200109",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000020001",
"N0000185504",
"N0000185503",
"N0000190113",
"N0000191423",
"N0000193932",
"N0000193845"
],
"upc": [
"0372064125303",
"0372064150305",
"0372064110309",
"0372064130307"
],
"unii": [
"513P80B4YJ"
],
"rxcui": [
"2272112",
"2272118",
"2272120",
"2272122",
"2272124",
"2272126",
"2559723",
"2559725",
"2559727",
"2559729"
],
"spl_set_id": [
"645c887c-8cd4-4623-8da9-ac223d71a8b9"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Tyrosine Kinase Inhibitors [MoA]",
"Cytochrome P450 2C9 Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
"Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]",
"Bile Salt Export Pump Inhibitors [MoA]"
],
"manufacturer_name": [
"Blueprint Medicines Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72064-130_6cecbec7-c35a-4993-9bb0-b16b2ad6bc21"